about
ANKH variants associated with ankylosing spondylitis: gender differencesNovel genetic markers in the 5'-flanking region of ANKH are associated with ankylosing spondylitisPreventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccineAltered host:pathogen interactions conferred by the Blau syndrome mutation of NOD2Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related lociChlamydia trachomatis vacuole maturation in infected macrophagesTumor necrosis factor inhibitor therapy in ankylosing spondylitis: differential effects on pain and fatigue and brain correlates.Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity.Rodent models of lymphocyte migration.Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's diseaseMolecular mimicry and autoimmunity.The genetic basis of ankylosing spondylitis: new insights into disease pathogenesisCombination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial.Bone morphogenetic protein 6 polymorphisms are associated with radiographic progression in ankylosing spondylitis.Autoantibodies to the HLA-B27 sequence cross-react with the hypothetical peptide from the arthritis-associated Shigella plasmid.Infectious agents in chronic rheumatic diseases.Retroperitoneal fibrosis: an extraarticular manifestation of ankylosing spondylitis.Bacterial triggers and autoimmune rheumatic diseases.Predicting the outcome of ankylosing spondylitis therapyIntracellular survival and persistence of Chlamydia muridarum is determined by macrophage polarization.Anti-tumour necrosis factor alpha therapy for ankylosing spondylitis: international experienceGenetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis.Ocular inflammation in HLA-B27 transgenic mice reveals a potential role for MHC class I in corneal immune privilege.Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis.Molecular and cellular biology of new bone formation: insights into the ankylosis of ankylosing spondylitis.Microbiome and probiotics: link to arthritis.Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeksGenome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci.Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1.ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patientsNotochordal cells protect nucleus pulposus cells from degradation and apoptosis: implications for the mechanisms of intervertebral disc degenerationGolimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE studyPathogenesis of ankylosing spondylitis and reactive arthritis.Alterations of bone mineral density, bone microarchitecture and strength in patients with ankylosing spondylitis: a cross-sectional study using high-resolution peripheral quantitative computerized tomography and finite element analysis.Mechanisms of disease: infection and spondyloarthritis.Testing of the preliminary OMERACT validation criteria for a biomarker to be regarded as reflecting structural damage endpoints in rheumatoid arthritis clinical trials: the example of C-reactive protein.Private rare deletions in SEC16A and MAMDC4 may represent novel pathogenic variants in familial axial spondyloarthritis.Validity of ankylosing spondylitis diagnoses in The Health Improvement Network.
P50
Q24816663-22064981-2963-4AC4-B845-51D3527B1ABCQ28182601-AE8C84B3-3938-4F2C-8FE3-C0D99C8452DAQ28200149-C2EB1108-1EF6-484F-8F62-E2161A0BE8C4Q28273372-5D4C1694-9812-4D88-8A5A-74288C673AA4Q29417082-512DECFB-8734-46C5-9E66-3B560DD13AF6Q30417517-8E3EFD0D-C4BC-46A9-86A5-A42DFFF89623Q30580283-B201C8CA-7E1E-4DD1-81DB-7042B2AA4A68Q30884907-FBD3852F-3387-4448-93EF-FA9B3AD80CE0Q33193663-32B6EDFE-0712-4E10-9D83-1C39F34607F6Q33636023-0153D7B8-FF26-4EDB-8219-C799F84AE29DQ33769709-91058D17-E2B4-4D39-AD1C-1FD82EDF5426Q33806107-6F33FD7E-4FA6-4261-B43A-CA2A6F1D2754Q33806334-79766BF8-1FED-4D72-82A0-1740AC54DC23Q34007328-2C83434E-7932-40D5-BCF3-3E37D491308BQ34046853-200B102B-25B0-45E2-B0F8-C0748CA7CB43Q34261751-85E1C487-C167-463F-9D70-AE6B3E0BDA86Q34368888-7F5AA73C-B421-43AA-AAE7-712C4DD2982EQ34601767-438D33AB-3CBE-4B71-AD06-393901CE2ED5Q34788126-EE54158C-97C4-47B2-B065-3757D7F1992AQ34905433-6D9B6CA3-5334-428B-B591-C9BA18792A50Q34962285-63CA8C0A-8E6E-468D-8674-FCE4D7ED4B44Q34967541-C674517A-FDAB-49B7-AD15-CEBF6ED383DDQ34996471-A4C911D7-E8F2-4111-A082-941650A10E3EQ35070276-4750455E-E736-43A2-B162-07A07B378D49Q35144333-30F25ED1-4EF8-4A5B-976A-1663DF21DC43Q35159517-0E188A1E-C053-4A11-B594-944E51249D08Q35170981-26E70EC7-2F22-4588-A421-4349C34E3820Q35554952-DD35F955-B8A0-455E-93ED-27A29B8E1BC1Q35575555-58C29464-DCFC-4692-9DC6-9468990653BCQ35605461-6BA976C0-BAEA-460D-BC86-9A7924495A2DQ35645174-C528997C-045E-4CCE-9629-61A47BF656BCQ35842117-B70EF713-63BD-4413-B8AB-23C0E1601A0DQ35907855-89A12A7E-D9EC-45ED-8DF7-5F365E26036BQ36020178-CCE868E8-704D-4BE0-A9D5-B35A74011758Q36163430-A3D5E14C-919C-4234-A6AB-969D88B189E3Q36477404-48F87B26-79B5-40B6-AC74-F49EFCA4E2F3Q36577443-99FD576F-7455-4F2E-9FB9-B129DB58B57FQ36753659-3D7FA16B-E106-4FA8-B453-071A857B14CFQ36761961-F2D03A04-60AA-4DBD-8A2E-300CCD27A3D8Q36784606-F362BF8A-40F8-453A-B224-4A2167771B5F
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Robert D Inman
@nl
Robert D Inman
@sl
Robert D. Inman
@en
Robert D. Inman
@es
type
label
Robert D Inman
@nl
Robert D Inman
@sl
Robert D. Inman
@en
Robert D. Inman
@es
prefLabel
Robert D Inman
@nl
Robert D Inman
@sl
Robert D. Inman
@en
Robert D. Inman
@es
P106
P1153
35392987100
P21
P31
P496
0000-0002-4750-1422